Evaluating the metabolic alterations in pancreatic cancer

Aneesha Dasgupta, Surendra K. Shukla, Venugopal Gunda, Ryan J. King, Pankaj Singh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Metabolic reprograming is an established hallmark of cancer cells. Pancreatic cancer cells, by virtue of the underlying oncogenic drivers, demonstrate metabolic reprograming to sustain growth, invasiveness, and therapy resistance. The increased demands of the growing tumor cells alter the metabolic and signaling pathways to meet the growing nutrient requirements. Investigating the metabolic vulnerabilities of tumor cells can help in developing effective therapeutics to target pancreatic cancer. In this chapter, we explain in detail the methods to evaluate the metabolic changes occurring in the tumor. This includes the glucose/glutamine uptake assays and the measurement of reactive oxygen species, extracellular acidification rate, and oxygen consumption rate in the tumor cells. All these physiological assays help in understanding the metabolic nature of the tumor.

LanguageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages221-228
Number of pages8
DOIs
StatePublished - Jan 1 2019

Publication series

NameMethods in Molecular Biology
Volume1882
ISSN (Print)1064-3745

Fingerprint

Pancreatic Neoplasms
Neoplasms
Metabolic Networks and Pathways
Glutamine
Oxygen Consumption
Reactive Oxygen Species
Glucose
Food
Therapeutics
Growth

Keywords

  • Cancer metabolism
  • ECAR
  • Glucose uptake
  • Glutamine uptake
  • OCR
  • Pancreatic cancer
  • Reactive oxygen species

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Dasgupta, A., Shukla, S. K., Gunda, V., King, R. J., & Singh, P. (2019). Evaluating the metabolic alterations in pancreatic cancer. In Methods in Molecular Biology (pp. 221-228). (Methods in Molecular Biology; Vol. 1882). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8879-2_20

Evaluating the metabolic alterations in pancreatic cancer. / Dasgupta, Aneesha; Shukla, Surendra K.; Gunda, Venugopal; King, Ryan J.; Singh, Pankaj.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 221-228 (Methods in Molecular Biology; Vol. 1882).

Research output: Chapter in Book/Report/Conference proceedingChapter

Dasgupta, A, Shukla, SK, Gunda, V, King, RJ & Singh, P 2019, Evaluating the metabolic alterations in pancreatic cancer. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1882, Humana Press Inc., pp. 221-228. https://doi.org/10.1007/978-1-4939-8879-2_20
Dasgupta A, Shukla SK, Gunda V, King RJ, Singh P. Evaluating the metabolic alterations in pancreatic cancer. In Methods in Molecular Biology. Humana Press Inc. 2019. p. 221-228. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-8879-2_20
Dasgupta, Aneesha ; Shukla, Surendra K. ; Gunda, Venugopal ; King, Ryan J. ; Singh, Pankaj. / Evaluating the metabolic alterations in pancreatic cancer. Methods in Molecular Biology. Humana Press Inc., 2019. pp. 221-228 (Methods in Molecular Biology).
@inbook{316d082bd79648c1b6feeadd52f6539c,
title = "Evaluating the metabolic alterations in pancreatic cancer",
abstract = "Metabolic reprograming is an established hallmark of cancer cells. Pancreatic cancer cells, by virtue of the underlying oncogenic drivers, demonstrate metabolic reprograming to sustain growth, invasiveness, and therapy resistance. The increased demands of the growing tumor cells alter the metabolic and signaling pathways to meet the growing nutrient requirements. Investigating the metabolic vulnerabilities of tumor cells can help in developing effective therapeutics to target pancreatic cancer. In this chapter, we explain in detail the methods to evaluate the metabolic changes occurring in the tumor. This includes the glucose/glutamine uptake assays and the measurement of reactive oxygen species, extracellular acidification rate, and oxygen consumption rate in the tumor cells. All these physiological assays help in understanding the metabolic nature of the tumor.",
keywords = "Cancer metabolism, ECAR, Glucose uptake, Glutamine uptake, OCR, Pancreatic cancer, Reactive oxygen species",
author = "Aneesha Dasgupta and Shukla, {Surendra K.} and Venugopal Gunda and King, {Ryan J.} and Pankaj Singh",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-8879-2_20",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "221--228",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Evaluating the metabolic alterations in pancreatic cancer

AU - Dasgupta, Aneesha

AU - Shukla, Surendra K.

AU - Gunda, Venugopal

AU - King, Ryan J.

AU - Singh, Pankaj

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Metabolic reprograming is an established hallmark of cancer cells. Pancreatic cancer cells, by virtue of the underlying oncogenic drivers, demonstrate metabolic reprograming to sustain growth, invasiveness, and therapy resistance. The increased demands of the growing tumor cells alter the metabolic and signaling pathways to meet the growing nutrient requirements. Investigating the metabolic vulnerabilities of tumor cells can help in developing effective therapeutics to target pancreatic cancer. In this chapter, we explain in detail the methods to evaluate the metabolic changes occurring in the tumor. This includes the glucose/glutamine uptake assays and the measurement of reactive oxygen species, extracellular acidification rate, and oxygen consumption rate in the tumor cells. All these physiological assays help in understanding the metabolic nature of the tumor.

AB - Metabolic reprograming is an established hallmark of cancer cells. Pancreatic cancer cells, by virtue of the underlying oncogenic drivers, demonstrate metabolic reprograming to sustain growth, invasiveness, and therapy resistance. The increased demands of the growing tumor cells alter the metabolic and signaling pathways to meet the growing nutrient requirements. Investigating the metabolic vulnerabilities of tumor cells can help in developing effective therapeutics to target pancreatic cancer. In this chapter, we explain in detail the methods to evaluate the metabolic changes occurring in the tumor. This includes the glucose/glutamine uptake assays and the measurement of reactive oxygen species, extracellular acidification rate, and oxygen consumption rate in the tumor cells. All these physiological assays help in understanding the metabolic nature of the tumor.

KW - Cancer metabolism

KW - ECAR

KW - Glucose uptake

KW - Glutamine uptake

KW - OCR

KW - Pancreatic cancer

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=85055652941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055652941&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-8879-2_20

DO - 10.1007/978-1-4939-8879-2_20

M3 - Chapter

T3 - Methods in Molecular Biology

SP - 221

EP - 228

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -